The AS suppression of NFATc1 is consistent with NFATc1’s potential oncogenic role in colon cancer, while the stimulation of NFATc2 by p53 suggests NFATc2 may function as a tumor suppressor22. The gene discussed is TP53; the disease is neoplasm.